TNFRSF9 and otitis media with effusion: The probability of each regimen to be the most superior was shown in Supplementary Table S5, which indicated that ILA (SUCRA = 1.0, 95% CI: 0.7143–1.0), PAN (SUCRA = 0.8571, 95% CI: 0.5714–1.0), RAB (SUCRA = 0.5714, 95% CI: 0.4286–1.0), OME (SUCRA = 0.5714, 95% CI: 0.4286–0.8571), and LAN (SUCRA = 0.4286, 95% CI: 0.4286–0.8571) were the top five regimens, respectively.